Manufacturers of flame retardant chemicals, an industry that got a boost from Big Tobacco's shadow money decades ago, are being exposed to increased public scrutiny. In the fallout, a front group formed by the three biggest manufacturers, calling itself "Citizens for Fire Safety," has been shuttered.
As part of a GOP effort to distance itself from the offensive remarks on "legitimate" rape recently made by Rep. Todd Akin, GOP Vice President nominee Paul Ryan has joined in the pleas aimed at the Congressman to pull out of Missouri's fall Senate race. Ryan would not discuss the details of a phone call he made to his friend and anti-abortion ally, but the conversation must have been awkward. Akin was only articulating the view that there should be no exception for rape or incest that he and Ryan both attempted to legislate into law in vote after vote in Congress.
A bill to improve reporting standards for toxic chemicals has passed out of committee to the U.S. Senate for a vote, and anti-regulatory czar Cass Sunstein has headed back to academia.
When it's not sailing along on government largesse -- like the $2.7 billion granted by U.S. Virgin Islands to help sell rum -- the global corporation that owns Captain Morgan flies a very different flag. It is a corporate leader of the American Legislative Exchange Council (ALEC), flying the flag of "limited government."
With millions of small business owners in the United States, why can multiple news outlets find only one small business owner to say that federal health care reform will negatively impact business?
By Brendan Fischer and Laura Stiegerwald
The evening after the U.S. Supreme Court upheld the Patient Protection and Affordable Care Act, the Wisconsin chapter of the Koch-funded Americans for Prosperity held a "Hands Off My Health Care" rally to plan next steps in their effort to defeat "Obamacare." The plan apparently involves American Legislative Exchange Council (ALEC) model legislation.
CNN jumped the gun this morning when it erroneously announced that the Supreme Court had struck down the Affordable Care Act's individual mandate -- appearing to side with the court's most vocal critics of the healthcare overhaul.
At 10:11 EDT the CNN headline read "Mandate Struck Down" and opined "the ruling overturns requirement that Americans must buy health insurance. The decision will affect you, generations of Americans and this fall's presidential race."
The lead plaintiff in the U.S. Supreme Court challenge to the Patient Protection and Affordable Care Act, the National Federation for Independent Business (NFIB), is a highly partisan front group masquerading as the "nation's leading small business association," critics say. The nation's highest court is expected to rule on the federal health care law Thursday.
In the midst of a scandal over allowing a corporation to skirt punishment for records showing it dumped large amounts of human sewage sludge on land, the Wisconsin Department of Natural Resources (DNR) has now refused to require the corporation, Herr Environmental, to test for contamination of nearby wells.
The U.S. House of Representatives is scheduled to vote Wednesday, May 30, on the Food and Drug Administration Reform Act of 2012, H.R.5651. Groups advocating for open and transparent government have found a provision in the bill that would keep potentially important health and safety information away from the public. Section 812 would, according to a letter to leaders of the House Oversight and Government Reform Committee penned by several of these groups, deny the public access to information relating to drugs obtained by the U.S. Food and Drug Administration (FDA) from any government agency -- local, state, federal, or foreign -- if that agency has requested that the information be kept confidential.
Patrice McDermott, Executive Director of OpenTheGovernment.org, which works with the legislative and executive branches to encourage more open government, told the Center for Media and Democracy (CMD) that the provision might blow a huge hole in the Freedom of Information Act (FOIA). It would give the FDA carte blanche with regard to drug information.